Trailing-twelve-month (TTM) revenue is $1.90 Billion with a year-over-year growth of +29.38%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $460,353,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $473,552,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $472,935,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $491,872,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $1,898,712,000 |
Current P/S: $2,099,551,170 market capitalization ÷ $1,898,712,000 TTM revenue = 1.11x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:25:13.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $491.87M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:26:14.823Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2016-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20122012-12-31 · USD | FY20132013-12-31 · USD | FY20142014-12-31 · USD | FY20152015-12-31 · USD | FY20162016-12-31 · USD |
|---|---|---|---|---|---|
| Portfolio Purchasing and Recovery | $545M | N/A | N/A | N/A | N/A |
| Portfolio Purchasing And Recovery | N/A | $756M | $1.0B | $1.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Europe | $490M | $487M | $403M | $430M | $322M | $495M |
| Non-US | N/A | $499M | N/A |
$1.90B
$1.90 Billion
+29.38%
vs. $1.47B a year ago (TTM)
+3.09%
5 Year compound annual growth rate
1 Year
+29.38%
3 Year
+17.26%
5 Year
+3.09%
10 Year
+5.10%
15 Year
+10.60%
20 Year
+10.80%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.76B | +$446.16M | +33.89% |
| 2024 | $1.32B | +$93.68M | +7.66% |
| 2023 | $1.22B | ($175.67M) | (12.56%) |
| 2022 | $1.40B | ($216.15M) | (13.39%) |
| 2021 | $1.61B | +$113.10M | +7.53% |
| 2020 |
TTM Growth
+29.38%
3-Year CAGR
+17.26%
5-Year CAGR
+3.09%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Tax Lien Business | N/A | $17M | $29M | $32M | $5M |
|---|
| Tax Lien Transfer | $10M | N/A | N/A | N/A | N/A |
|---|
| N/A |
| N/A |
| Other European Countries | N/A | N/A | $130M | $134M | $90M | $141M |
|---|
| Other Geographies | $18M | $12M | $178,000 | $370,000 | $2M | $5M |
|---|
| UNITED STATES | $993M | $1.1B | $995M | $792M | $992M | $1.3B |
|---|
| $1.50B |
| +$103.72M |
| +7.42% |
| 2019 | $1.40B | +$35.65M | +2.62% |
| 2018 | $1.36B | +$174.99M | +14.74% |
| 2017 | $1.19B | +$157.78M | +15.33% |
| 2016 | $1.03B | ($100.71M) | (8.91%) |
